Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.


greensprout

GW Pharma US blanket patent is denied

Ha. Serves them right for trying to corner the market with their massively overpriced product.
:toldya::toldya:


https://www.beardbrospharms.com/news/2019/1/9/gw-pharma-denied-blanket-patent-on-treating-epilepsy-with-cannabinoids?fbclid=IwAR0lyvumY61R2d5nA-pSt6kSNbwsUg-5WERM6mnuFeY50HizKv7xgpd5eos
 

GW Pharma Denied Blanket Patent on Treating Epilepsy with Cannabinoids

Small victories are still victories

When UK-based GW Pharmaceuticals successfully convinced the FDA and the DEA to allow them to bring their cannabis-derived CBD isolate tincture to the U.S. market last year, surely some bottles got popped at the GW HQ as their anti-seizure medication, Epidiolex, stood unimpeded on a path to piles of cash.

When the federal government somehow got organized enough to pass the 2018 Farm Bill in December of last year, GW Pharma likely breathed a sigh of relief and chugged a bit more bubbly once their buds at the FDA clarified that even though the hemp plant is no longer illegal, many products utilizing hemp-derived CBD still would be.

So, yes, we celebrate small victories when we can, and last week we got one from the U.S. patent Office.

U.S. Patent #9066920B2 has been in the works since 2010, but on January 3rd of this year, the application was officially, and in no uncertain terms, denied.

“unpatentable”

Here’s what they were asking to patent, look for the key words right at the beginning of this abstract:

This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.

Ok so generally speaking, it appears that GW Pharma was looking to put a patent on treating epilepsy with CBD and/or THCV. But did you find the real razor in the apple above?

The dangerously ambiguous term “use of one or more cannabinoids…” intentionally leaves too much legal wiggle room for them to potentially weaponize that patent to discourage competition.

Epidiolex is said to come with a $32,000+ price tag for a one year treatment, so stifling competition helps their bottom line.

If Epidiolex is safe and helps even one child – and there are success stories – then GW Pharma is doing great work and their product belongs on the market. . . but then so do countless other brands and options that currently have no hope of FDA and DEA approval.

They are certainly not the only company trying to make an end run on plant-based patents in the cannabis space so it will be interesting to continue to watch how the U.S. Patent Office decides to rule on future cases.

GW Pharma, with their exclusive blessing from the federal government, is in a wholly unique position to really do some good. Their public relations has suffered through the arduous process of gaining those approvals, but future efforts to help preserve the cannabis culture could go a long way toward regaining some respect from the grassroots, for whatever that’s worth to them.

Having this patent denied does not stop them from helping sick kids.
It stops them from stopping others from helping sick kids.

Thank you to the U.S. Patent Office for seeing it that way.

As the legalization movement gains momentum worldwide, cannabis-based research will only deepen our knowledge of the plant and its many benefits. Fueling that momentum in large part will be our rapidly improving technology as we refine breeding, cultivating, processing, and testing methods.

We’re seeing that now as science begins to accurately map the genome of cannabis and as exciting as that is, it also opens the door to the potential for smothering monopolies and corporate influence the likes of which our culture and this industry are just now starting to witness.

So we fight back and celebrate small victories.

 

3 people like this

Share this post


Link to post

@greensprout Thanks for that, most interesting.  For epidolex they seem to be using CBD and THCV rich low THC cannabis.  I think THCV is naturally rare and found in native thai strains.

 

Makes sense now why Thailand are going to open up the market.... I smell GWP's dirty little fingers in this now.

Share this post


Link to post
1 hour ago, greensprout said:

Epidiolex is said to come with a $32,000+ price tag for a one year treatment

 

:shock:

 

or grow a few plants in your house..'knock' knock 'who's that dear? the police!

 

its a stick up with no gun and they're pointing it at sick kids and their parents!

2 people like this

Share this post


Link to post

I wonder how much sativex costs.... I get prescribed 20 boxes a year, that is 60 bottles, yes, 5 per month, one bottle lasts 6 days... after 12+ years I can be quite precise... anyone know how much I am costing the NHS?

1 person likes this

Share this post


Link to post
11 hours ago, Rex Mundi said:

I wonder how much sativex costs.... I get prescribed 20 boxes a year, that is 60 bottles, yes, 5 per month, one bottle lasts 6 days... after 12+ years I can be quite precise... anyone know how much I am costing the NHS?

 

 

Afaik your hospital gets it at cost @ £125/bottle.

£7500 / year :yep:

1 person likes this

Share this post


Link to post
7 hours ago, bartman said:

 

 

Afaik your hospital gets it at cost @ £125/bottle.

£7500 / year :yep:

Hmm, it was that price long ago, so it seems that there is no inflation increase over the years... of course that is afayk.... I wonder if it has gone up since we first found this out years ago...

you say "at cost" but I assume you meant "at cost of" because we both know there is only about a tenners worth of cannabinoids in sativex, if that... so their costs are probably about that perhaps.

1 person likes this

Share this post


Link to post

@Rex Mundi

 

Yes you are right. I meant the cost that gw pharma knock it out at. This I believe is still £125 per bottle.

When third party suppliers/pharmacists  get involved the cost of each bottle that is charged to the NHS can escalate the price dramatically.

 

1 person likes this

Share this post


Link to post

i've seen it for £150 a bottle online a couple of years ago..

Share this post


Link to post
2 hours ago, twigs said:

i've seen it for £150 a bottle online a couple of years ago..

I'm shocked that someone would pay that for it... if, just if mind, I've never tried, but if I was to use a whole bottle in one day I don't think it would get me "stoned", that's what I grow for...

Share this post


Link to post

it was from an online pharmacy i think?

Share this post


Link to post
11 minutes ago, Rex Mundi said:

I'm shocked that someone would pay that for it... if, just if mind, I've never tried, but if I was to use a whole bottle in one day I don't think it would get me "stoned", that's what I grow for...

 

 I don't think your average MS patient particulary cares if they get stoned or not

Share this post


Link to post
40 minutes ago, elmer budd said:

 

 I don't think your average MS patient particulary cares if they get stoned or not

Agreed... I wrongly assumed it was an illegal black market deal, but it was a genuine legal one in a pharmacy.... my mistake.

Share this post


Link to post

@Rex Mundi To be fair, mate, talking about cannabis and prices is usually an illegal black market deallol

 

Edit: Not around here, obviously

Edited by elmer budd

Share this post


Link to post

£125 / bottle is still the current price.

https://bnf.nice.org.uk/medicinal-forms/cannabis-extract.html

 

note that NICE are incorrect though when they list active ingredients of Sativex.

They claim it contains Dronabinol. WALOB!!

 

CANNABIS EXTRACT

 

Spray All products

Excipients

May contain

Propylene glycol

Sativex oromucosal spray  (Bayer Plc)

  • Schedule 4 (CD Benz)
Active ingredients Size Unit NHS indicative price Drug tariff Drug tariff price
  • Cannabidiol 2.5 mg per 1 dose
  • Dronabinol 2.7 mg per 1 dose
270 dose (POM) £375.00 Part VIIIA Category C £375.00

 

1 person likes this

Share this post


Link to post

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now